Skip to main content
High RiskFDAfda-F-1951-2015UNDECLARED ALLERGEN

GetGo Giant Eagle Strawberry Yogurt Parfait Sell By: (up to and including) 3/24/2015 Distributed by: Giant Eagle, Inc., Pittsburgh, PA...

Category
Units Affected
1,682
Recall Date
March 19, 2015
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1951-2015.

Giant Eagle label review found that labels of GetGo Strawberry Yogurt Parfait failed to declare the soy allergen from soy lecithin in the granola ingredient.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1951-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Giant Eagle, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1951-2015.

Giant Eagle, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Giant Eagle, Inc. Recall FAQ

Giant Eagle, Inc. is the subject of a dairy safety report: GetGo Giant Eagle Strawberry Yogurt Parfait Sell By: (up to and including) 3/24/2015 Distributed by: Giant Eagle, Inc., Pittsburgh, PA.... The notice was published on March 19, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 1,682 units are potentially affected.